MedPath

Occupational Therapist-Led Work Intervention in Facilitating Work Maintenance or Re-entry to the Workforce in Patients With Stage I to III Breast Cancer Undergoing Chemotherapy

Not Applicable
Terminated
Conditions
Breast Cancer Stage IIB
Breast Cancer Stage III
Breast Cancer Stage IIA
Breast Cancer Stage IIIc
Breast Cancer Stage I
Breast Cancer Stage II
Breast Cancer Stage IIIB
Breast Cancer Stage IIIA
Breast Cancer
Interventions
Behavioral: Occupational Therapy
Registration Number
NCT03723863
Lead Sponsor
University of Washington
Brief Summary

This trial studies how well occupational therapy (occupational therapist-led work intervention) works in facilitating work maintenance or re-entry to the workforce for stages I to III breast cancer patients who will be undergoing curative intent chemotherapy. Occupational therapy may help cancer patients maintain employment or successfully return to work soon after treatment.

Detailed Description

Patients receive in-person occupational therapist-led work consultation.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
15
Inclusion Criteria
  • Stage I-III breast cancer patients who will be undergoing curative intent chemotherapy
  • Working in a paid capacity (part or full-time) at time of diagnosis with the intent to maintain or return to work following treatment
Read More
Exclusion Criteria
  • Non-English speaking patients. This study requires completing online questionnaires that are written in English and will not be translated
  • Patients with a psychiatric or neurological condition that impairs capacity to make decisions
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Supportive care (Occupational therapy)Occupational TherapyPatients receive in-person occupational therapist-led work consultation
Primary Outcome Measures
NameTimeMethod
Change in perceived work abilityBaseline up to 3 years

Will be measured by the Work Abilities Index (WAI).

Secondary Outcome Measures
NameTimeMethod
Change in health related quality of lifeBaseline up to 3 years

Will be measured by the Functional Assessment of Cancer Therapy General (FACT-G), a validated measure for quality of life in patients with cancer.

Change in financial toxicityBaseline up to 3 years

Will be measured by the Comprehensive Score for Financial Toxicity (COST-FACIT), a validated measure for financial toxicity for clinically relevant patient-centered outcomes.

Trial Locations

Locations (1)

Fred Hutch/University of Washington Cancer Consortium

🇺🇸

Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath